Latest Conference Articles

Rheumatologists and OB-GYNs must communicate openly with each other and to patients with rheumatic diseases who are considering pregnancy.

An expert discusses the state of screening, diagnosing, and treating osteoarthritis and osteoporosis.

Which composite measures detect the highest level of changes in psoriatic disease activity.

In the MONARCH OLE study, more than 50% of patients with rheumatoid arthritis who had low or inadequate response to adalimumab and switched to sarilumab experienced an improvement in disease activity.

Patient assessments measured fatigue, disease activity, global spinal pain, and spinal pain at night.

How providers of multiple specialists can come together to help 1 patient.

An expert dermatologist explains.

COVID-19 is associated with its own cytokine storm syndrome.

A majority of patients with the condition are on azathioprine or mycophenolate mofetil and mycophenolic acid.

These findings suggest the possibility of a common underlying disease process between the two pathologies.

When a rheum patient might need to consult with a dermatologist.

HRV-induced cytokine responses were reduced in patients with severe asthma.

Pulmonary conditions like asthma could often lead to the development of chronic cough.

Despite not being able to attend conferences live, there are some advantages to a virtual conference.

How the 2 specialties play a role in each other.

Filgotinib was well-tolerated and sustained efficacy in a 52-week extension study.

The molecular mechanisms of steroid resistance suggest the P13K/Akt signaling pathway and the MAPK signaling pathway are involved.

An expert discusses the risks that rheumatic diseases pose for pregnancies as well as the conversations rheumatologists need to have with their patients.

A post-hoc analysis of 3 randomized controlled trials reports on the associations between the IL-6 inhibitor and unacceptable or refractory pain.

Other measures, like home oxygen dependency, all-cause mortality, and hospitalization for respiratory failures rates, had no apparent association with RF and/or ACPA status

Alternate therapies can be more effective than opioids.

New cohort analysis shows an over-reliance on therapy designed as an add-on for asthma control.

Twelve-year data shows patients without control of their asthma could suffer lung failure quickly if they aren't consistent in maintenance therapy.

Asthma patients have not had higher rates of negative outcomes from COVID-19 than other individuals.

There were no new safety signals and efficacy was sustained through 156 weeks.

The biologic drug is set to be used as a combination therapy for asthma.

Facets of managing pain for rheumatology patients.

According to a poster presented at CCR East 2020, patients <60 and ≥60 years old achieved minimal disease activity and cDAPSA low disease or remission.

In a study presented at ERS, researchers IOS could be used for assessment level of asthma control in both adult and pediatric patients.

Early initiation following fragility fractures helps manage osteoporosis.